Punch & Associates Investment Management, Inc. Harvard Bioscience Inc Transaction History
Punch & Associates Investment Management, Inc.
- $1.62 Billion
- Q2 2024
A detailed history of Punch & Associates Investment Management, Inc. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Punch & Associates Investment Management, Inc. holds 2,772,339 shares of HBIO stock, worth $6.51 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
2,772,339
Previous 2,772,339
-0.0%
Holding current value
$6.51 Million
Previous $11.8 Million
32.78%
% of portfolio
0.49%
Previous 0.71%
Shares
16 transactions
Others Institutions Holding HBIO
# of Institutions
105Shares Held
32MCall Options Held
1.2KPut Options Held
1.2K-
Black Rock Inc. New York, NY2.84MShares$6.68 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.56MShares$6.01 Million0.9% of portfolio
-
Amh Equity LTD2.2MShares$5.17 Million8.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$4.98 Million0.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.93MShares$4.52 Million0.23% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $97.8M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...